Voluntary Recall on Ranitidine Expanded

  • November 21, 2019

    The voluntary recall of Ranitidine has been expanded to include additional manufacturers.

    On October 23, 2019, the voluntarily recall of Ranitidine in the US to the consumer level because of confirmed contamination with N-Nitrosodimethylamine (NDMA) has been expanded to include capsules and syrups manufactured by Dr. Reddy’s, Lannet Company, and Novitium Pharma.

    Patients are asked to continue taking their medication and speak to their provider about alternate healthcare treatment options. Pharmacies will be asked to immediately stop dispensing Ranitidine.

    Visit the FDA website for more information on the recalled products including product names, catalog numbers, lot numbers, and expiration dates. For other questions, email provider.relationswest@premera.com.

  •    Email this article